Skip to content

Family History Study of Alcohol Consumption Using Memantine

NMDA Antagonist Efficacy in Reducing Human Alcohol Consumption: Impact of Family History

Status
Completed
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00630955
Enrollment
111
Registered
2008-03-07
Start date
2006-06-30
Completion date
2011-08-31
Last updated
2020-03-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alcohol Drinking

Keywords

Alcohol Drinking, Memantine

Brief summary

The purpose of this study is to evaluate the effects of the study medication, memantine (placebo, 20 mg or 40 mg/day) on alcohol drinking behavior in a laboratory setting in which participants are given an initial drink of alcohol followed by the choice to drink up to 12 more drinks over a three-hour period. We hypothesize that memantine will reduce craving and number of drinks consumed prior to and after exposure to the initial drink of alcohol and during the three hour drinking period. We will also evaluate the influence of family history of alcoholism on the efficacy of memantine in reducing alcohol drinking behavior.

Interventions

DRUGmemantine

Memantine 20 mg once per day for 7 days

DRUGMemantine

Memantine 40 mg once per day for 7 days

DRUGPlacebo

Placebo once per day for 7 days

Sponsors

National Institute on Alcohol Abuse and Alcoholism (NIAAA)
CollaboratorNIH
Yale University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
TRIPLE (Subject, Caregiver, Investigator)

Eligibility

Sex/Gender
ALL
Age
21 Years to 50 Years
Healthy volunteers
No

Inclusion criteria

* Ages 21-50 * Able to read English at 6th grade level or higher and to complete study evaluations * Regular alcohol drinker

Exclusion criteria

* Individuals who are seeking alcohol treatment * Medical conditions that would contraindicate the use of memantine * Regular use of other substances

Design outcomes

Primary

MeasureTime frameDescription
Number of Drinks Consumed on Day 7Day 7
Baseline-adjusted Craving (YCS)Day 7Craving for alcohol based on Yale Craving Scale, scores ranging from 0-112 mm on a visual analog scale, with higher measurements indicating higher craving. The baseline-adjusted craving is change score from baseline at Day 7.

Secondary

MeasureTime frameDescription
Stimulation Responses to AlcoholDay 7Brief Biphasic Alcohol Effects Scale-Stimulation subscale, measuring stimulation effects of alcohol on Day 7, 6 items, 11-point rating scale from 0=Not at All to 10=Extremely, total scores ranging from 0 - 30, with higher measurements indicating higher stimulation.
Sedation Responses to AlcoholDay 7Brief Biphasic Alcohol Effects Scale-Sedation subscale, measuring sedation effects of alcohol on Day 7, 6 items, 11-point rating scale from 0=Not at All to 10=Extremely, total scores ranging from 0 - 30, with higher measurements indicating higher sedation.

Countries

United States

Participant flow

Recruitment details

Participants were recruited from May 2006-May 2011 using posted advertisements in the local newspaper and brochures and other materials distributed in the community (bars, coffee shops, grocery stores).Electronic media and social networking were also used, including Craigslist and Facebook.

Participants by arm

ArmCount
0 mg Memantine34
20 mg Memantine37
40 mg Memantine40
Total111

Baseline characteristics

Characteristic20 mg Memantine40 mg Memantine0 mg MemantineTotal
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
0 Participants0 Participants0 Participants0 Participants
Age, Categorical
Between 18 and 65 years
37 Participants40 Participants34 Participants111 Participants
Age, Continuous32.4 years
STANDARD_DEVIATION 9.3
31.3 years
STANDARD_DEVIATION 8.8
29.1 years
STANDARD_DEVIATION 7.2
31.0 years
STANDARD_DEVIATION 8.6
Region of Enrollment
United States
37 participants40 participants34 participants111 participants
Sex: Female, Male
Female
12 Participants13 Participants11 Participants36 Participants
Sex: Female, Male
Male
25 Participants27 Participants23 Participants75 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
deaths
Total, all-cause mortality
— / —— / —— / —
other
Total, other adverse events
22 / 3424 / 3731 / 40
serious
Total, serious adverse events
0 / 340 / 370 / 40

Outcome results

Primary

Baseline-adjusted Craving (YCS)

Craving for alcohol based on Yale Craving Scale, scores ranging from 0-112 mm on a visual analog scale, with higher measurements indicating higher craving. The baseline-adjusted craving is change score from baseline at Day 7.

Time frame: Day 7

ArmMeasureValue (LEAST_SQUARES_MEAN)Dispersion
0 mg MemantineBaseline-adjusted Craving (YCS)20.2 millimetersStandard Error 2.16
20 mg MemantineBaseline-adjusted Craving (YCS)14.1 millimetersStandard Error 2.23
40 mg MemantineBaseline-adjusted Craving (YCS)21.4 millimetersStandard Error 2.23
Primary

Number of Drinks Consumed on Day 7

Time frame: Day 7

ArmMeasureValue (MEAN)Dispersion
0 mg MemantineNumber of Drinks Consumed on Day 75.84 standard drinksStandard Deviation 3.67
20 mg MemantineNumber of Drinks Consumed on Day 75.61 standard drinksStandard Deviation 4.6
40 mg MemantineNumber of Drinks Consumed on Day 76.21 standard drinksStandard Deviation 4.61
Secondary

Sedation Responses to Alcohol

Brief Biphasic Alcohol Effects Scale-Sedation subscale, measuring sedation effects of alcohol on Day 7, 6 items, 11-point rating scale from 0=Not at All to 10=Extremely, total scores ranging from 0 - 30, with higher measurements indicating higher sedation.

Time frame: Day 7

Population: Analysis includes all those who had complete data, which is less than those listed in the Participant Flow module

ArmMeasureValue (MEAN)Dispersion
0 mg MemantineSedation Responses to Alcohol3.286 units on a scaleStandard Deviation 5.381
20 mg MemantineSedation Responses to Alcohol3.964 units on a scaleStandard Deviation 6.327
40 mg MemantineSedation Responses to Alcohol3.37 units on a scaleStandard Deviation 5.085
Secondary

Stimulation Responses to Alcohol

Brief Biphasic Alcohol Effects Scale-Stimulation subscale, measuring stimulation effects of alcohol on Day 7, 6 items, 11-point rating scale from 0=Not at All to 10=Extremely, total scores ranging from 0 - 30, with higher measurements indicating higher stimulation.

Time frame: Day 7

Population: Analysis includes all those who had complete data, which is less than those listed in the Participant Flow module

ArmMeasureValue (MEAN)Dispersion
0 mg MemantineStimulation Responses to Alcohol4.643 units on a scaleStandard Deviation 4.923
20 mg MemantineStimulation Responses to Alcohol4.321 units on a scaleStandard Deviation 5.313
40 mg MemantineStimulation Responses to Alcohol6.444 units on a scaleStandard Deviation 6.536

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026